These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures. Pfister P; Hobbie S; Vicens Q; Böttger EC; Westhof E Chembiochem; 2003 Oct; 4(10):1078-88. PubMed ID: 14523926 [TBL] [Abstract][Full Text] [Related]
7. Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: an analysis of x-ray crystal structures. Vicens Q; Westhof E Biopolymers; 2003 Sep; 70(1):42-57. PubMed ID: 12925992 [TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
9. Antibacterial drug discovery and structure-based design. Barker JJ Drug Discov Today; 2006 May; 11(9-10):391-404. PubMed ID: 16635801 [TBL] [Abstract][Full Text] [Related]
10. The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography. Russell RJ; Murray JB; Lentzen G; Haddad J; Mobashery S J Am Chem Soc; 2003 Mar; 125(12):3410-1. PubMed ID: 12643685 [TBL] [Abstract][Full Text] [Related]
11. A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site. Foloppe N; Chen IJ; Davis B; Hold A; Morley D; Howes R Bioorg Med Chem; 2004 Mar; 12(5):935-47. PubMed ID: 14980606 [TBL] [Abstract][Full Text] [Related]
12. Drugs targeting the ribosome. Hermann T Curr Opin Struct Biol; 2005 Jun; 15(3):355-66. PubMed ID: 15919197 [TBL] [Abstract][Full Text] [Related]
13. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
14. Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases. Pokrovskaya V; Nudelman I; Kandasamy J; Baasov T Methods Enzymol; 2010; 478():437-62. PubMed ID: 20816493 [TBL] [Abstract][Full Text] [Related]
15. Molecular recognition between the ribosomal decoding site and natural or non-natural aminoglycosides. Westhof E Nucleic Acids Symp Ser (Oxf); 2005; (49):59-60. PubMed ID: 17150632 [TBL] [Abstract][Full Text] [Related]
16. Using X-ray crystallography in drug discovery. Rowland RS Curr Opin Drug Discov Devel; 2002 Jul; 5(4):613-9. PubMed ID: 12197319 [TBL] [Abstract][Full Text] [Related]
17. Towards the discovery of drug-like RNA ligands? Foloppe N; Matassova N; Aboul-Ela F Drug Discov Today; 2006 Nov; 11(21-22):1019-27. PubMed ID: 17055412 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic blocks mRNA path on the ribosome. Mankin A Nat Struct Mol Biol; 2006 Oct; 13(10):858-60. PubMed ID: 17021617 [No Abstract] [Full Text] [Related]
19. Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach. Perdih A; Kovac A; Wolber G; Blanot D; Gobec S; Solmajer T Bioorg Med Chem Lett; 2009 May; 19(10):2668-73. PubMed ID: 19369074 [TBL] [Abstract][Full Text] [Related]
20. Molecular contacts between antibiotics and the 30S ribosomal particle. Wirmer J; Westhof E Methods Enzymol; 2006; 415():180-202. PubMed ID: 17116475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]